BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 14, 2020
View Archived Issues
Dual mu-opioid/nociceptin receptor agonist BPR-1M97 shows advantages over morphine
Read More
Death, taxes and zoonotic spillover
Read More
Phase I trial of INO-5150 immunotherapy against PSA/PSMA in biochemically relapsed prostate cancer
Read More
An innovative 3D fiber-reinforced hydrogel for the regeneration of corneal stroma
Read More
Exosomes deliver sepsis treatment
Read More
Dopamine has epigenetic role in addiction
Read More
Koselugo receives FDA approval for pediatric patients with NF1-related plexiform neurofibromas
Read More
Metacrine patents farnesoid X receptor agonists
Read More
SOX4-dependent regulation of a subset of tRNA genes controls human glioblastoma cell proliferation
Read More
New melanocortin MC4 receptor agonists identified at Palatin Technologies
Read More
Bristol-Myers Squibb discovers lysophosphatidic acid receptor 1 antagonists
Read More
Loss-of-function mutation in BK channel reduces mitochondrial viability, causing progressive ataxia
Read More
Phase III study of tislelizumab plus chemotherapy in NSCLC meets primary endpoint
Read More
Roche, Genentech describe new MAP4K1 inhibitors
Read More
FDA lifts clinical hold on phase III study of TG-C
Read More
New small-molecule inhibitor of enterovirus 71 for the treatment of hand, foot and mouth disease
Read More
Goldfinch Biopharma presents new TRPC5/TRPC4 antagonists
Read More
Potent and selective sphingosine kinase 2 inhibitor targeting a small side cavity
Read More
Ridgeback Biotherapeutics initiates phase I study of EIDD-2801 for COVID-19
Read More
PLOD1 mutation tied to smooth muscle cell dysfunction and aortopathy
Read More
Bausch Health initiates clinical trial of Virazole in patients with COVID-19
Read More
BioInvent reports early responses in phase I/IIa study of BI-1206 for NHL
Read More
AstraZeneca to unblind phase III ADAURA trial of Tagrisso early based on efficacy
Read More
Lilly advances plans to evaluate baricitinib and LY-3127804 for COVID-19
Read More
